Bayer AG (BAYRY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
Bayer AG ( BAYRY ) is on track to meet its full-year targets for sales growth, core earnings per share, and free cash flow. The Pharmaceuticals division is performing well, with Nubeqa reaching blockbuster status and strong growth in other launch products. Consumer Health division achieved a 6% year-over-year sales growth in the third quarter, driven by strong performance in cough and cold products. The company is making significant progress in its strategic agenda, including innovation in its Pharma pipeline and operational efficiency improvements. Bayer AG ( BAYRY ) has successfully scaled its new operating model, resulting in a leaner organization with improved decision-making processes. The Crop Science division is facing challenges, with sales expected to decline due to weather issues, commodity price softness, and generic pricing pressure. Regulatory challenges, particularly in the Crop Science division, could have a material impact on top and bottom lines in 2025.
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Michael L. Baum, Esq. Renowned Advocate Added to Board of Gene Guard Detox, Inc. [Yahoo! Finance]Yahoo! Finance
- Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments [Yahoo! Finance]Yahoo! Finance
- Agrochemicals Market Poised for Significant Growth, Projected to Reach $282.2 Billion by 2028 [Yahoo! Finance]Yahoo! Finance
- Pet Supplements Market to Reach $4.68 Billion by 2031- Exclusive Report by Meticulous Research® [Yahoo! Finance]Yahoo! Finance
- Watermelon Seeds Market Analysis Report 2025-2030, Featuring Bayer CropScience, Vilmorin & Cie, Syngenta, Origene Seeds, GoldSupplier, Tokita Seed Co., Emerald Seed Company & Hazera [Yahoo! Finance]Yahoo! Finance